Biologic differences between peripheral and transition zone prostate cancer

Prostate

Volumn 75, Issue 2, 2015, Pages 183-190

  Lee, J Joy ^a   Thomas, I Chun ^a   Nolley, Rosalie ^a   Ferrari, Michelle ^a   Brooks, James D ^a   Leppert, John T ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Peripheral zone prostate cancer; Prostate neoplasms; Prostate specific antigen; Prostatectomy; Transition zone prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; COMPARATIVE STUDY; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL ZONE PROSTATE CANCER; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE FREE SURVIVAL; RISK REDUCTION; SEMINAL VESICLE INVASION; TRANSITIONAL ZONE PROSTATE CANCER; TUMOR INVASION; TUMOR LOCALIZATION; AGED; BLOOD; COHORT ANALYSIS; FOLLOW UP; PATHOLOGY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; TRENDS;

AGED; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84923277577     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22903     Document Type: Article

References (28)

1. Augustin H, Erbersdobler A, Graefen M, Fernandez S, Palisaar J, Huland H, Hammerer P. Biochemical recurrence following radical prostatectomy: A comparison between prostate cancers located in different anatomical zones. The Prostate 2003;55(1): 48-54.
2. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12:897-906.
3. Elgamal AA, Van Poppel HP, Van de Voorde WM, Van Dorpe JA, Oyen RH, Baert LV. Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens - A different view. J Urol 1997;157: 244-250.
4. Noguchi M, Stamey TA, Neal JE, Yemoto CE. An analysis of 148 consecutive transition zone cancers: Clinical and histological characteristics. J Urol 2000;163:1751-1755.
5. Sakai I, Harada K, Kurahashi T, Yamanaka K, Hara I, Miyake H. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones. Int J Urol 2006;13:368-372.
6. Augustin H, Hammerer PG, Blonski J, Graefen M, Palisaar J, Daghofer F, et al. Zonal location of prostate cancer: Significance for disease-free survival after radical prostatectomy? Urology 2003;62:79-85.
7. Greene DR, Wheeler TM, Egawa S, Dunn JK, Scardino PT. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 1991;146:1069-1076.
8. King CR, Ferrari M, Brooks JD. Prognostic significance of prostate cancer originating from the transition zone. Urol Oncol 2009;27:592-597.
9. McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread. Hum Pathol 1992;23:258-266.
10. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999;281:1395-1400.
11. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 1990; 66:1225-1233.
12. McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA. Patterns of progression in prostate cancer. Lancet 1986;1:60-63.
13. Ferrari MK, McNeal JE, Malhotra SM, Brooks JD. Vascular invasion predicts recurrence after radical prostatectomy: Stratification of risk based on pathologic variables. Urology 2004;64: 749-753.
14. Erbersdobler A, Fritz H, Schnoger S, Graefen M, Hammerer P, Huland H, et al. Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone. Eur Urol 2002;41:40-46.
15. Grignon DJ, Sakr WA. Zonal origin of prostatic adenocarcinoma: Are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland? J Cell Biochem Suppl 1994;19:267-269.
16. Sowalsky AG, Ye H, Bubley GJ, Balk SP. Clonal progression of prostate cancers from Gleason grade 3 to grade 4. Cancer Res 2013;73:1050-1055.
17. Kovtun IV, Cheville JC, Murphy SJ, Johnson SH, Zarei S, Kosari F, et al. Lineage relationship of Gleason patterns in Gleason score 7 prostate cancer. Cancer Res 2013;73:3275-3284.
18. Lavery HJ, Droller MJ. Do Gleason patterns 3 and 4 prostate cancer represent separate disease states? J Urol 2012;188:1667-1675.
19. Yoshimoto M, Joshua AM, Cunha IW, Coudry RA, Fonseca FP, Ludkovski O, et al. Absence of TMPRSS2: ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Mod Pathol 2008;21:1451-1460.
20. Falzarano SM, Navas M, Simmerman K, Klein EA, Rubin MA, Zhou M, et al. ERG rearrangement is present in a subset of transition zone prostatic tumors. Mod Pathol 2010;23:1499-1506.
21. Guo CC, Zuo G, Cao D, Troncoso P, Czerniak BA. Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion. Mod Pathol 2009;22:866-871.
22. Liu S, Yoshimoto M, Trpkov K, Duan Q, Firszt M, Corcos J, et al. Detection of ERG gene rearrangements and PTEN deletions in unsuspected prostate cancer of the transition zone. Cancer Biol Ther 2011;11:562-566.
23. Sakai I, Harada K, Hara I, Eto H, Miyake H. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones. BJU Int 2005;96:528-532.
24. Gopalan A, Leversha MA, Satagopan JM, Zhou Q, Al-Ahmadie HA, Fine SW, et al. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res 2009;69:1400-1406.
25. Stamey TA, Yemoto CM, McNeal JE, Sigal BM, Johnstone IM. Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 2000;163:1155-1160.
26. Wong LM, Toi A, Van der Kwast T, Trottier G, Alibhai SM, Timilshina N, et al. Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progression. J Urol 2014; DOI: 10.1016/j.juro.2014.04.010
27. Yao MH, Zou LL, Wu R, Guo LH, Xu G, Xie J, et al. Transperineal ultrasound-guided 12-core prostate biopsy: An extended approach to diagnose transition zone prostate tumors. PLoS ONE 2014;9:e89171.
28. Wang CC, Carter HB, Epstein JI. Value of transition zone biopsy in active surveillance of prostate cancer. J Urol 2013; DOI: 10.1016/j.juro.2013.11.058